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1. Introduction  
Encephalitis is a poorly defined disease entity. Encephalitic symptoms may be vague and 
unspecific, especially in the neonatal and pediatric age groups. Early signs and symptoms 
such as fever, malaise, headache and fatigue are fairly common and shared with many 
disease entities, infectious and non-infectious. Even if neurologic symptoms prevail and an 
encephalitis diagnosis has moved to the top of the list of differential diagnoses, overlap with 
other disease entities remains a possibility - in particular with meningitis, cerebellitis, 
myelitis and acute disseminated encephalomyelitis (ADEM). 
Encephalitis appears to be under-diagnosed and in the majority of cases of encephalitis, the 
pathogen or cause remain unknown.1-5 Furthermore, surveillance programs in Scandinavia 
revealed that 60% of the children with encephalitis had persisting symptoms at the time of 
discharge. Systematic evidence-based research and prospective surveillance are warranted to 
learn more about the clinical spectrum, underlying causes, and prognostic factors of 
encephalitis. The ultimate goal of encephalitis clinical research should be to improve treatment 
modalities and disease outcomes in all patients, regardless of age and geographic background.  
Meaningful epidemiologic investigations of encephalitis disease outcomes, incidence and 
prevalence require large-scale studies, multi-centric approaches, and the pooling and meta-
analysis of significant amounts of data from different parts of the world. For data comparability 
purposes, pre-defined standards should be used for the inclusion of patients into encephalitis 
surveillance cohorts. Inclusion criteria for encephalitis studies should be based on observer-
independent, widely accepted clinical case definitions and ideally, international consensus. 
This paper aims to raise awareness of the challenges of defining and diagnosing encephalitis 
as a disease entity, while presenting a number of practical approaches to facilitate 
encephalitis screening for pediatric clinical research and public health purposes.   
2. Problem 
Very few large-scale studies have been conducted to date monitoring the incidence and 
prevalence of encephalitis, and even fewer targeting the paediatric age group. Usually, these 
studies are set up as laboratory-based investigations or with a specific disease entity or 
pathogen in mind such as West Nile Virus6, Japanese Encephalitis Virus (JEV), tick borne 
encephalitis (TBE), rotavirus, varicella and other herpesviruses.   
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Examples of key topics in encephalitis studies in recent years are: 
 The early detection of congenital encephalitis and TORCH infections 
 Regional and periodic epidemiologic surveillance of arbovirus infections 
 Polio surveillance (WHO) 
 Baseline prevalence of vaccine preventable disease  
 Monitoring of adverse events following immunization (AEFI)  
Example 1: The discussion around Rotavirus Encephalitis/ Encephalopathy 
Ever since the first cases of CNS involvement in rotavirus disease were reported, it has been 
discussed if and when one of the most common pathogens causing gastroenteritis in 
children under the age of 4 may also cause neurologic symptoms and complications. Table 1 
illustrates a summary of the first case reports of rotavirus encephalitis in the medical 
literature.   
 
Case, Reference Location Year Age Sex 
Neurological 
Diagnosis 
Stool CSF Blood Outcome 
1. Salmi et al. 7 Finland 1978 2 yr F Seizures EM   Patient died 
2. Salmi et al. 7 Finland 1978 3 yr F Seizures EM  NCDV Slow recovery 
3. Wong et al. 8 USA 1984 6 mo M 
Aseptic 
meningitis 
EIA, IEM 
EIA, IEM, 
pleocytosis
 Healthy 
4. Ushijima et al. 9 Japan 1986 9 mo M Acute encephalitis
PAGE, 
Latex 
agglutinati
on (LA), 
EM, RV 
IgA 
RV IgG, 
IgA, IgM 
RV IgG, 
IgA, 
IgM, 
CFT 
Coma x 10 d, 
infantile 
spasms, 
developmental 
delay 
5. Keidan et al. 10 Israel 1992 2 yr M Encephalopathy EIA EM  Healthy 
6. Keidan et al.10 Israel 1992 21 mo M Encephalopathy EIA   Healthy 
7. Yoshida et al.11 Japan 1995 2 yr F Encephalitis 
Latex 
agglutinati
on (LA) 
RT-PCR, 
pleocytosis
 Healthy 
8. Pang et al. 12 Finland 1996 9 mo F Febrile seizures 
EIA, RT-
PCR 
RT-PCR 
RT-PCR, 
RV IgG, 
IgA 
Healthy 
9. Makino et al. 13 Japan 1996 21 mo F Encephalopathy 
EIA, RT-
PCR 
RT-PCR 
RT-PCR, 
CFT 
Hemiparesis, 
mental 
retardation 
10. Hongou et al.14  Japan 1998 2 yr M Encephalitis LA 
RT-PCR, 
RV IgG, 
pleocytosis
CFT Healthy 
11. Pager et al.15 
South 
Africa 
2000 1yr M Seizures LA RT-PCR  
Pat. died first 
day of life 
12. Lynch et al. 16 USA 2001 6 yr M Seizures EIA RT-PCR RV IgA 
Pat. died after 5 
mo 
13. Lynch et al. 16 USA 2001 2.5 yr F Encephalitis EIA RT-PCR  Healthy 
14. Goldwater et al. 17 Australia 2001 2.5 yr M Encephalitis EIA 
PCR, RT-
PCR 
 
Slow recovery, 
sequelae 
(hypotonia, 
unclear speach) 
15. Goldwater et al. 17 Australia 2001 13 mo M Encephalopathy EIA RT-PCR  
Moderate 
hemiparesis 
16. Nigrovic et al. 18 USA 2002 3 yr F Cerebellitis RT-PCR RT-PCR  
Wide-base gait, 
moderate 
expressive 
aphasia 
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Case, Reference Location Year Age Sex 
Neurological 
Diagnosis 
Stool CSF Blood Outcome 
17. Morrison19 USA 2001 4 yr  
Encephalitis, 
cerebral edema, 
uncal herniation 
 
CNS in 
situ RT-
PCR, in 
situ 
hybridizati
on 
 Patient died 
18. Kobata et al. 20 Japan 2002 2 yr F Encephalopathy 
Immunoch
romatogra
phy, EM, 
RT-PCR 
  Healthy 
19. Iturriza-Gomarra 
et al. 21 
UK 2002 2 yr M Seizures 
LA, RT-
PCR 
RT-PCR  Healthy 
20. Kehle et al. 22 Germany 2003 9 mo F 
Meningo-
encephalitis 
EIA 
RT-PCR, 
pleocytosis
IgM Healthy 
21. Rath et al.23 USA 2004 8 mo M Encephalitis EIA 
 RT-PCR, 
probe 
hybridizati
on 
 
Mental 
retardation, 
dystonia, 
developmental 
delay 
22. Nakagomi et al.24 Japan  2005 1.5 yr M 
Not reported in 
detail. 
Manifestations 
included 
encephalitis, 
encephalopathy, 
convulsions or 
seizures. 
ELISA or 
LA 
 ELISA 
Not reported 
23. Nakagomi et al.24 Japan  2005 0.5 yr M 
ELISA or 
LA 
 ELISA 
24. Nakagomi et al.24 Japan  2005 4 yr F 
ELISA or 
LA 
 ELISA 
25. Nakagomi et al.24 Japan  2005 3 yr F 
ELISA or 
LA 
 ELISA 
26. Nakagomi et al.24 Japan  2005 2.5 yr M 
ELISA or 
LA 
 ELISA 
27. Nakagomi et al.24 Japan  2005 1.5 yr F 
ELISA or 
LA 
RT-PCR  
28. Nakagomi et al.24 Japan  2005 9 yr F 
ELISA or 
LA 
RT-PCR  
29. Nakagomi et al.24 Japan  2005 2 yr F 
ELISA or 
LA 
RT-PCR  
30. Kirton et al.25 Canada 2005 15 mo F 
Necrotizing 
encephalopathy 
EIA   Patient died 
31. Shiihara et al.26 Japan 2007 2.5 yr F 
Encephalitis, 
Cerebellitis 
Immunoch
romatogra
phy, RT-
PCR Pleocytosis 
(RT-PCR -)
 
Slow speech 
and dysarthria  
31. Shiihara et al.26 Japan 2007 4.5 yr M 
Encephalitis, 
Cerebellitis 
Immunoch
romatogra
phy 
Slow speech, 
dysarthria, 
hand tremor 
32. Furuya et al.27 Japan 2007 3.5 yr F Encephalitis RT-PCR RT-PCR   Not reported 
Table 1. 
Notably, thirty-three cases of rotavirus disease with CNS involvement had been reported up 
until the time when the new rotavirus vaccines were introduced in the United States. 16-22 25-
28 Among these 32 cases, less than half (10/24; 42%) of the patients with reported outcomes 
recovered completely. Five children (21%) died from the disease, whereas the remaining 
37% experienced neurological sequelae. 23 
With increased awareness evidence has since grown further, and CNS involvement is 
slowly being recognized as a rare but potentially serious complication in rotavirus 
gastroenteritis.29-38 Over time, in addition to viral diagnostics radiological features of 
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rotavirus encephalitis are better understood, which may help in directing clinicians to the 
correct diagnosis. 23 37 
During and prior to the time of rotavirus vaccine introduction in different parts of the 
world, large rotavirus surveillance programs have been instituted. Despite the size and 
number of such programs, meta-analysis is difficult as very little information can be 
obtained on rare complications of rotavirus disease. Studies were designed measuring 
different endpoints and inconsistent criteria and definitions have been applied (if any) for 
CNS complications. 
An exception for surveillance studies of seizures in rotavirus disease: 
A subanalysis of a 5- year rotavirus surveillance in Salt Lake City, Utah (2002-6) is a rare 
exception specifically focusing of CNS complications. Investigators retrospectively 
identified 34/59 children with laboratory-confirmed rotavirus infection and >=1 seizure 
without an alternative medical explanation. They reported one child with cerebral edema on 
neuroimaging and abnormal EEG and 2 children (7%) who required chronic anticonvulsant 
therapy concluding “…that seizures associated with rotavirus infection are a relatively 
benign neurologic condition in young children. With few exceptions, neurodiagnostic 
studies do not influence management or outcome.“39.  
Precise data and incidence rates with respect to encephalitis/ encephalopathy in large-scale 
rotavirus surveillance programs are sill lacking. In the meantime, CNS complications have 
also been reported in gastroenteritis due to other viruses such as norovirus 40 and 
adenovirus 41. 
Example 2: Encephalitis as a vaccine preventable disease 
A number of recent encephalitis surveillance studies have been focusing on vaccine 
preventable disease, such as tick borne encephalitis (TBE) and Japanese encephalitis virus 
(JEV). 
Systematic tick born encephalitis studies have recently been conducted in Eastern European 
countries where the disease is endemic, such as Slovenia 42, Poland 43, and Latvia 44. A 
common European approach has been sought by VENICE (http://venice.cineca.org/ 
final_report_TBE_19-01-2011.pdf) and several others 45, 46, 47 however, universal criteria for 
the clinical assessment and grading of encephalitis still remain to be implemented.  
With respect to Japanese Encepahlitis Virus (JEV), surveillance has recently been extended 
to many Asian countries including Bangladesh 48, Nepal 49, Japan 48, to name only a few. 
New WHO criteria for JEV have been defined and evaluated. 50 More recently, general 
systemativ surveillance programs and monitoring activities preparing the introduction of 
JEV vaccine have been developed by PATH in Vietnam, and Nepal 
(http://www.path.org/publications/detail.php?i=1523).  
With the introduction of varicella vaccine, varicella zoster virus (VZV) has become the 
first vaccine preventable disease caused by herpesviridae. Complications of VZV disease 
include CNS involvement with the clinical picture of encephalitis/cerebellitis. Neurologic 
complications in VZV infection are common in, but not restricted to immuno-
compromized patients 51 and may even occur in the context of reactivation (varicella 
zoster). 52 
A 1-year surveillance of hospitalizations for VZV complications was conducted in 1997 in 
485 German pediatric hospitals including neurologic complications, bacterial 
superinfections, and hematologic complications (with multiple entries permitted in the 
surveillance questionnaire). Notably, neurologic complications were among the most 
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common with 61.3% (in comparison to infectious complications with 38.6%). Among CNS 
complications, cerebellitis was predominant with 40.3%, followed by encephalitis (18.4%) 
and meningitis (1.7%) and facial palsy (0.8%). 53 Similar studies have recently been 
conducted in Italy 54, 55, UK, Ireland, 56 and Saudi Arabia 57. 
Parallel to increased efforts in developing a cytomegalovirus (CMV) vaccine 58-61, attention 
has also shifted to further understanding the neurologic sequelae and disease burden of 
congenital CMV disease and non-immunocompromised hosts. 62-22 
In addition, influenza has been increasingly recognized as a vaccine preventable cause of 
encephalitis, especially in children and adolescents. 67 Initial reports emerged from Japan 
and the United States 68-75 and recently, a number of case reports as well as surveillance 
reports by CDC have been issued on neurologic complications of Influenza A (in particular 
pandemic H1N1) disease. 76-88 
Example 3: Encephalitis as an adverse event following immunization (AEFI) 
Encephalitis has not only been described as a viral and/or immunological illness, but also as 
an adverse event following immunization (AEFI)89. The British Pediatric Surveillance Unit 
conducted  a 3-year prospective surveillance aiming to investigate encephalitis as an AEFI in 
the UK and Ireland90  
By nature, AEFI are rare events requiring large-scale studies, meta-analyses, or extensive 
(ideally active) surveillance programs to be detected. Reporting bias and awareness are 
major obstacles to the systematic assessment of AEFI. Resent research revealed that 
physicians are more likely to report a specific AE if the AE constitutes an event a vaccine in 
designed to prevent. Interestingly, this “reverse placebo effect” also applied to non-live 
vaccines. 91 
When data have to be pooled from a number of different studies, the use of uniform 
diagnostic criteria is warranted allowing comparability among studies conducted at 
different sites. This demand has been met by the Brighton Collaboration, who published a 
clinical case definition for encephalitis as an AEFI in 2007. 89 The diagnostic criteria 
for encephalitis as an AEFI are listed in Table 2, below. The Brighton Collaboration criteria 
are designed to capture an adverse event independent from any potential triggers, but also 
to differentiate reliably and consistently between different kinds of CNS involvement, 
including meningitis, meningo-encephalitis, myleitis, ADEM and the like.  
The Brighton Collaboration case definitions for aseptic meningitis, encephalitis, myelitis and 
ADEM have since been evaluated in a retrospective analysis of 255 clinical cases of CNS 
disease in a Swiss children’s hospital. 93 This evaluation study revealed that unless 
predefined clinical criteria are applied consistently, the demarcation of closely related 
but distinct CNS disease entities will be missed. ICD-10 coding and diagnoses mentioned in 
hospital discharge summaries are insufficient and all too often observer-dependent. 93 
 
Brighton Collaboration Case Definition for Encephalitis as an AEFI 89 
“Case definitions: encephalitis, myelitis, and ADEM”1 
 
Encephalitis - Level 1 of diagnostic certainty:2 
 
(a) Demonstration of acute inflammation of central nervous system parenchyma (± 
meninges) by histopathology. 
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Encephalitis - Level 2 of diagnostic certainty:3,4 
 
(a) Encephalopathy (e.g. depressed or altered level of consciousness, lethargy, or 
personality change lasting >24 h), 
 
AND INCLUDING 
 
(b) ONE OR MORE of the following: 
1. Decreased or absent response to environment, as defined by response to loud noise or 
painful stimuli, 
2. Decreased or absent eye contact, 
3. Inconsistent or absent response to external stimuli, 
4. Decreased arousability, 
5. Seizure associated with loss of consciousness.92 
OR 
(c) Focal or multifocal findings referable to the central nervous system, including one or 
more of the following: 
1. Focal cortical signs (including but not limited to: aphasia,alexia, agraphia, cortical 
blindness), 
2. Cranial nerve abnormality/abnormalities,5 
3. Visual field defect/defect(s), 
4. Presence of primitive reflexes (Babinski’s sign, glabellar reflex, snout/sucking reflex), 
5. Motor weakness (either diffuse or focal; more often focal)5 
6. Sensory abnormalities (either positive or negative; sensory level), 
7. Altered deep tendon reflexes (hypo- or hyperreflexia, reflex asymmetry), 
8. Cerebellar dysfunction, including ataxia, dysmetria, cerebellar nystagmus. 
 
AND (for both possibilities to reach Level 2) 
(d) TWO OR MORE6 of the following indicators of inflammation of the CNS: 
1. Fever (temperature ≥38° C), 
2. CSF pleocytosis (>5WBC/mm3 in children >2 months of age; >15WBC/mm3 in children 
<2  months of age), 
3. EEG findings consistent with encephalitis,7 or 
4. Neuroimaging consistent with encephalitis.8 
 
Encephalitis - Level 3 of diagnostic certainty:3,4 
 
(a) Encephalopathy (e.g. depressed or altered level of consciousness, lethargy, or 
personality change lasting >24 h), 
 
AND INCUDING 
(b) ONE OR MORE of the following: 
1. Decreased or absent response to environment, as defined by response to loud noise or 
painful stimuli, 
2. Decreased or absent eye contact, 
3. Inconsistent or absent response to external stimuli, 
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4. Decreased arousability, or 
5. Seizure associated with loss of consciousness. 92 
OR 
(c) Focal or multifocal findings referable to the central nervous system, including one or 
more of the following: 
1. Focal cortical signs (including but not limited to: aphasia, alexia, agraphia, cortical 
blindness), 
2. Cranial nerve abnormality/abnormalities,5 
3. Visual field defect/defect(s), 
4. Presence of primitive reflexes (Babinski’s sign, glabellar reflex, snout/sucking reflex), 
5. Motor weakness (either diffuse or focal; more often focal), 5 
6. Sensory abnormalities (either positive or negative; sensory level), 
7. Altered deep tendon reflexes (hypo- or hyperreflexia, reflex asymmetry), or 
8. Cerebellar dysfunction, including ataxia, dysmetria, cerebellar nystagmus. 
 
AND (for both possibilities to reach Level 3) 
 
(d) ONE7 of the following indicators of inflammation of CNS: 
1. Fever (temperature ≥38°C), 
2. CSF pleocytosis (>5WBC/mm3 in children >2 months of age; >15WBC/mm3 in children 
<2 months of age), 
3. EEG findings consistent with encephalitis,7 or 
4. Neuroimaging consistent with encephalitis.8 
 
Encephalitis - Level 3A of diagnostic certainty:7,9 
 
(a) Insufficient information is available to distinguish case between acute encephalitis or 
ADEM; case unable to be definitively classified. 
 
Encephalitis - Exclusion criterion for levels 2 and 3 of diagnostic certainty: 
 
(a) Other diagnosis for illness present.10 
 
2 If the lowest applicable level of diagnostic certainty of the definition for a definitive category (i.e., 
Level 3, excluding Level 3A) is met and there is evidence that the criteria of the next higher level of 
diagnostic certainty (Level 2) are met, the event should be classified in the next category. This 
approach should be continued until the highest level of diagnostic certainty for a given event can be 
determined. Thus, if a case fits diagnostic criteria for both categories (encephalitis and ADEM), but 
reaches a higher level of diagnostic certainty in one, the higher level supercedes, and the case should 
be classified according to the category in which the higher diagnostic certainty level is reached. 
TheWorking Group recognizes that under this paradigm, it is possible to reach a higher level of 
diagnostic certainty forADEMwith less stringent criteria than it is for encephalitis e.g., Level 1 
diagnostic certainty for encephalitis requires histopathologic diagnosis, whilst ADEM Level 1 does not 
require this. However, in the absence of a biological marker, the diagnosis of ADEM rests upon the 
proper neuroimaging findings in the appropriate clinical context, and the combination of appropriate 
neuroimaging and a monophasic pattern of illness are as close to a gold standard as exist for this 
clinical entity. Thus, one may have a higher level of diagnostic certainty of ADEM than of encephalitis, 
in the absence of other biologic data. When Level 1 ADEM and Level 2 encephalitis, or Level 2 ADEM 
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and 
Level 3 encephalitis are met, the best category to choose would be ADEM. 
3 The encephalitis/ADEMWorking Group recognizes that, in most cases, histopathologic examination 
of tissue will not be practicable as a method of diagnosis; this may particularly be the case in 
developing countries. However, histopathologic demonstration of cerebral inflammation remains the 
“gold standard” for the diagnosis of encephalitis, and as such, the group has determined that this 
should be Level 1 for determination of encephalitis. 
4 Levels 2 and 3 of diagnostics certainty have been especially designed for adults and children older 
than or equal to 2 years of age. For children under the age of 2 years (and, in particular, those under 
the age of 6 months) the nervous system and, as such, the neurologic examination is continually in 
flux (e.g., what is normal in a 28-day old is not necessarily normal in a 2- month old child). The 
evaluation of encephalopathy and neurologic deficits in infants and young children will need to be 
done in an age-appropriate fashion, taking into account the age and level of development of the child. 
5 Levels 2 or 3 of encephalitis are met if criteria (a+b+d) or (c+d) from the respective levels are fulfilled, 
and no exclusion criteria are met. 
6 Note that only criteria 2 and 5 may be applicable in all age groups; other criteria for focal/mulitfocal 
neurologic signs may be age-dependent, and will not be applicable to all age groups. 
7 Note that Level 2 of diagnostic certainty requires at least 2 of the listed criteria for inflammation, 
while Level 3 required only 1 criteria. This is in recognition that, in some cases of encephalitis, all 
listed criteria will either not be present, or such data will be unavailable. Thus, a clinical diagnosis of 
encephalitis should still be applicable, but will be of less diagnostic certainty than if sufficient criteria 
were present. 
8 Electroencephalographic (EEG) findings consistent with encephalitis:EEG findings consistent with 
encephalitis include, but are not limited to: Diffuse or multifocal nonspecific (nonphysiologic) 
background slowing; periodic discharges or other encephalographic abnormalities may or may not be 
present. 
9 Neuroimaging findings consistent with encephalitis: Neuroimaging findings consistent with 
encephalitis include, but are not limited to: head computed tomography (CT) displaying areas of 
hypodensity; contrast images demonstrating meningeal and parenchymal enhancement indicating 
meningeal and parenchymal inflammation, or gyral enhancement, brain/spine magnetic resonance 
imaging (MRI) displaying diffuse or multifocal areas of hyperintense signal on T2-weighted, 
diffusion-weighted image, or fluid-attenuation inversion recovery (FLAIR) sequences, suggestive of 
inflammation or demyelination. 
Tabe 2. Brighton Collaboration Case Definition for Encephalitis as an AEFI 
(see www.brightoncollaboration.org) 
3. Assessment of the problem 
Most of the attempts to standardize the diagnosis of encephalitis are focusing on adults 
whereas pediatric studies are facing specific challenges in the differential diagnosis, such as 
age-dependent symptoms while intellectual capabilities are still developing and the 
difficulty to distinguish acute neurologic impairment from consequences of perinatal 
asphyxia and congenital malformations, developmental delay, intoxication and other 
alternative possible non-infectious causes of encephalopathy.2, 5 Due to the immaturity of 
the immune system and the blood-brain barrier, children under the age of two are at a 
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particularly high risk of developing encephalitis during bacterial sepsis or systemic infection 
with herpesviridae, Tb and many other pathogens. At the same time the chance of 
recurrence of HSV meningo-encephalitis is difficult to assess and consequences of 
premature discontinuation of antiviral therapy can be detrimental. 94-99 Even in older 
children, the difficulty to identify symptoms of encephalopathy such as behavioral 
outbursts, decreased responsiveness, and other subtle signs may delay the diagnosis and 
thus, treatment. 100, 101 In other cases, the differentiation of autoimmune from viral causes of 
encephalitis causes problems. 100,4 Without the identification of potential causes of 
encephalitis, however, the treatment options and prognosis in different types of encephalitis 
will remain poorly understood.1, 102 
With additional diagnostic and therapeutic options becoming available, and several types of 
encephalitis vaccine-preventable, the systematic surveillance of encephalitis in children has 
gained significance, also with respect to everyday clinical care. 
As indicated above, prospective and retrospective case ascertainment both provide a 
number of challenges. Prospective surveillance of large cohorts using predefined case 
definitions is key to avoid inter-rater variability and selection bias.  The installment of active 
surveillance systems in specialized reference centers will ultimately improve the monitoring 
of encephalitis as an AEFI. Children with acute CNS adverse events are most likely to 
present in emergency rooms and tertiary care centers rather than private pediatric practices, 
where the child has usually been immunized. Unless immunizations are systematically 
captured at the time of investigation, rates of encephalitis and other CNS adverse events 
following immunization - as opposed to other triggers or causes -  can hardly be established. 
90, 103 In addition, lumbar puncture is difficult to perform in infants and children, and even if 
CSF has been obtained, pathogens other than HSV and bacteria are rarely assessed in 
routine practice. Very little is known for example, about incidence rates of enterovirus 
infection in pediatric CNS disease.104  However, effective enterovirus surveillance can also 
be utilized as a tool for regional polio disease surveillance, as is the case at the German 
National Reference Laboratory for Enteroviruses at the Robert Koch Institute in Berlin.105, 106 
Hospital-based prospective surveillance systems have been introduced in several 
locations, including country-wide surveillance systems in the US4, France107, the UK 2 and 
Sweden 1, as well as smaller programs in Taiwan 108, Crete 109, and India.110 Unfortunately, 
each of these programs use their own case definitions for encephalitis. 
Table three provides several examples of clinical case definitions used in recent pediatric 
encephalitis studies: 
 
First 
Author 
Title Country Type/Category 
Year(s) of 
Study 
Clinical Case Definition for Encephalitis 
Amin 67 
Acute childhood 
encephalitis and 
encephalopathy 
associated with 
influenza: a 
prospective 11-
year review 
Canada 
Influenza 
Encephalitis 
1994 - 2004
"Encephalopathy was defined as a 
depressed or altered level of consciousness 
persisting for 24 hours. Encephalitis was 
defined by the presence of encephalopathy 
plus 2 or more of the following criteria: 
fever (temperature 38.0°C), seizure(s), 
focal neurologic findings, cerebrospinal 
fluid (CSF) pleocytosis (WBC count  5   106 
cells/L), EEG findings compatible with 
encephalitis, or abnormal  
neuroimaging" 
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First 
Author 
Title Country Type/Category 
Year(s) of 
Study 
Clinical Case Definition for Encephalitis 
Anga 111 
The aetiology, 
clinical 
presentations 
and outcome of 
febrile 
encephalopathy 
in children in 
Papua New 
Guinea 
Papua New 
Guinea 
Febrile 
Encephalo-pathy 
ND 
"Children aged between 1 month and 12 
years presenting to Port Moresby General 
Hospital with febrile encephalopathy, 
defined as fever, seizures and/or altered 
consciousness" 
Beig 110 
Etiology and 
clinico-
epidemiological 
profile of acute 
viral 
encephalitis in 
children of 
western Uttar 
Pradesh, India 
India 
Acute viral 
encephalitis 
Jul 2004-
Nov 2006 
 
“Acute encephalopathy was defined as 
fever with alteration of consciousness 
and/or with neurological deficit, 
secondary to central nervous system 
involvement lasting more than 24 hours, 
and not more than a oneweek history. 
Patients with a different final diagnosis 
(e.g., epilepsy, febrile convulsion, bacterial 
meningitis, tuberculosis, brain tumor, 
cerebral malaria, or metabolic disorder) 
were excluded from the study.” 
Elbers 112 
A 12-year 
prospective 
study of 
childhood 
herpes simplex 
encephalitis: is 
there a broader 
spectrum of 
disease? 
USA HSV Encephalitis 1994-2005 
 
"Inclusion criteria for this registry are 
documented encephalopathy, defined as 
depressed or altered level of consciousness 
persisting for >24 hours, plus 2 of the 
following: fever (>38°C), seizure, focal 
central nervous system (CNS) findings, 
CSF pleocytosis (>5 x 106 cells per L), EEG 
abnormalities, or diagnostic imaging 
abnormalities (on brain computed 
tomography [CT]/MRI scans). Patients 
were excluded if they had underlying 
neurologic disease or were known to have 
immunosuppression. This study did not 
include cases of neonatal encephalitis and 
focused on children between 4 weeks and 
18 years of age. 
For identification of a cohort of children 
with clinically and diagnostically definite 
HSE, patients in our study fulfilled 
stringent inclusion criteria: the 
aforementioned criteria of the encephalitis 
registry, CSF PCR and/or serologic 
evidence of HSV infection, and 1 of the 
following: CSF abnormalities, including 
the presence of pleocytosis, >50 x 106 red 
blood cells (RBCs) per L, and/or elevated 
protein levels (>0.4 g/L), EEG readings 
consistent with HSE, or CT and MRI 
findings suggesting HSE, such as focal 
signal abnormalities or hemorrhage. 
Patients were excluded if an alternative 
diagnosis accounted for their  
symptoms." 
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First 
Author 
Title Country Type/Category 
Year(s) of 
Study 
Clinical Case Definition for Encephalitis 
Fowler 1 
Childhood 
encephalitis in 
Sweden: 
etiology, clinical 
presentation 
and outcome 
Sweden Encephalitis 2000-2004 
A. Age 1 month–18 years 
B. Signs of cerebral dysfunction either as. 
1. encephalopathy defined as altered 
consciousness, personality or behavioral 
changes lasting for more than 24 hr, or 2. 
abnormal EEG finding compatible with 
encephalitis, plus at least one of the 
following: - Abnormal results of 
neuroimaging compatible with 
encephalitis, -Positive focal neurological 
findings, -Seizures. 
C. Signs of inflammation, defined either as 
pleocytosis (X6 white blood cells/mL), 
fever (38C) or elevated infectious 
parameters (CRP,WBC). Mild symptoms 
from eyes, nose or throat were not 
considered to be sufficient." 
Ganerod 2 
Causes of 
encephalitis and 
differences in 
their clinical 
presentations in 
England: a 
multicentre, 
population-
based 
prospective 
study 
UK Encephalitis 
Oct 2005- 
Nov 2006 
 
"The case definition included any person 
of any age admitted to hospital with 
encephalopathy (altered consciousness 
that persisted for longer than 24 h, 
including lethargy, irritability, or a change 
in personality and behaviour) and with 
two or more of the following:fever or 
history of fever (≥38ºC) during the 
presenting illness; seizures and/or focal 
neurological fi ndings (with evidence of 
brain parenchyma involvement); CSF 
pleocytosis (more than four white blood 
cells per μL); electroencephalographic 
(EEG) fi ndings indicative of encephalitis; 
and abnormal results of neuroimaging 
(CTor MRI) suggestive of encephalitis." 
Glaser 113 
In search of 
encephalitis 
etiologies: 
diagnostic 
challenges in the 
California 
Encephalitis 
Project, 1998-
2000 
USA Encephalitis 1998-2000 
 
"A case was defined as encephalopathy 
(depressed or altered level of 
consciousness lasting 
 24 h, lethargy, or change in personality) 
requiring hospitalization with  1 of the 
following symptoms: fever, seizure, focal 
neurological findings, CSF pleocytosis, or 
electroencephalography or neuroimaging 
findings consistent with encephalitis.", > 6 
months of age  
Glaser 4 
Beyond viruses: 
clinical profiles 
and etiologies 
associated with 
encephalitis. 
USA Encephalitis 1998 -2005 
">= 6 months of  age, and met the CEP 
case definition of encephalitis. A “case 
patient” was defined as a patient 
hospitalized with encephalopathy 
(defined by a depressed or altered   
sonality change) with level of 
consciousness lasting  24 h, lethargy, or a 
per 1 of the following characteristics: 
fever, seizure, focal neurological findings, 
pleocytosis, or electroencephalography or 
neuroimaging findings consistent with 
encephalitis." 
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First 
Author 
Title Country Type/Category 
Year(s) of 
Study 
Clinical Case Definition for Encephalitis 
Ward 90 
Risk of Serious 
Neurologic 
Disease After 
Immunization of 
Young Children 
in Britain and 
Ireland 
Britain and 
Ireland 
Immunization   
 
“Case definiton of serious neurologic 
disease: children 2 to 35 month with 
suspected encephalitis and/or severe 
illness with fever and convulsions. 
Convulsion: total duration of >30 min OR 
followed by encephalopathy of 2-23h OR 
followed by paralysis or other 
neurological signs not previously present 
for ≥24h. Fever: ≥37.5°C. Encephalopathy: 
depressed or altered level of 
consciousness. Encephalitis: 
Encephalopathy for ≥24h and TWO of the 
following: fever, convulsions, focal 
neurological findings (≥24h), pleocystosis 
(>5 leucocytes per µl CSF), characteristic 
abnormal results of neuroimaging (CT or 
MRI), herpes simplex virus nucleis acid (or 
nucleic acid of any other virus proven to 
cause encephalitis) in CSF; OR 
postmortem histologic evidence of 
encephalitis. Exclusion criteria: viral 
meningitis without encephalopathy; the 
following confirmed causes: 
hypoxic/ischemic; vascular; toxic; 
metabolic, neoplastic, traumatic, pyogenic 
infections; uncomplicated convulsions or a 
series of convulsions lasting 30 min; 
immunocompromised children.” 
Hossain 48 
Hospital-based 
surveillance for 
Japanese 
encephalitis at 
four sites in 
Bangladesh, 
2003-2005.  
Bangladesh
Japanese 
Encephalitis 
2003-2005 
".. clinical case definition of acute 
encephalitis with indication for lumbar 
puncture, based on the judgment of the 
patient's attending physician. The clinical 
case definition of acute encephalitis 
included new onset of fever (temperature 
> 38°C) or history of fever during the 
present illness along with altered mental 
status, (e.g., confusion, disorientation, 
coma) and/or a neurological deficit (i.e., 
focal or diffuse neurological dysfunction 
or new onset of seizures) with onset of the 
neurological symptoms within five days 
prior to hospitalization. Enrollment in the 
study required that the patient met the 
clinical case definition and that he or she 
had cerebrospinal fluid (CSF) pleocytosis 
(defined as > 4 leukocytes/mm3 for 
patients > 6 weeks of age and > 14 
leukocytes/mm3 for the patients > 6 
weeks of age)..." 
Huang 102 
Long-term 
cognitive 
and motor 
deficits after 
enterovirus 71 
brainstem 
encephalitis in 
children 
Taiwan 
Enterovirus 
Encephalitis 
1998 - 2004
"case definition for enterovirus 71 
brainstem encephalitis: myoclonus, ataxia, 
nystagmus, oculomotor palsies, and 
bulbar palsy, in various combinations, 
with or without confirmation by 
neuroimaging". 
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First 
Author 
Title Country Type/Category 
Year(s) of 
Study 
Clinical Case Definition for Encephalitis 
Le 3 
Viral etiology of 
encephalitis in 
children in 
southern 
Vietnam: results 
of a one-year 
prospective 
descriptive 
study 
Vietnam Encephalitis 
Jan-Dec 
2004 
"Children admitted [..] with suspected acute 
encephalitis of viral origin, based on the 
clinical judgment of admitting physicians, 
and with no preexisting neurological 
conditions or evidence of bacterial 
meningitis by microscopy or culture of 
cerebrospinal fluid (CSF) samples, and no 
febrile convulsion (defined by a single 
convulsion lasting less than 15 minutes with 
regaining of consciousness within 60 
minutes in a child between 6 months and 6 
years of age) were eligible for inclusion in 
the study after provision of written 
informed consent by the patient’s parents or 
legal guardians" 
Lee 108 
Encephalitis in 
Taiwan: a 
prospective 
hospital-based 
study 
Taiwan Encephalitis 2000-2001 
"Encephalitis was defined as follows: acute 
and severe neurological dysfunction in the 
context of suspected encephalitis, which 
included signs and symptoms of acute 
mental dysfunction, memory impairment, 
LOC, pareses, abnormal behaviour, 
convulsions, and involuntary movement. 
The patient's EEG and/or CT scan and LP 
were also compatible with the diagnosis of 
encephalitis. Patients with high fever, 
headache, nausea and vomiting were 
excluded by LP, CT/MRI or EEG 
examination. Patients with other diseases, 
especially with other systemic infection 
(sepsis), cerebral vascular accident, 
neoplasm of the brain or psychiatric 
diseases that caused disturbed 
consciousness were also excluded by LP, 
CT/MI or EEG examination." 
Mailles 107 
Infectious 
encephalitis in 
France in 2007: a 
national 
prospective 
study 
France Encephalitis 
Jan-Dec 
2007 
"Inclusion criteria: age ≥ 28 days 
hospitalized in mainland France in 2007 
AND (1) acute onset of illness, (2) at least 1 
abnormality of the CSF (white blood cell 
count of ≥ 4 cells/mm³ OR protein level of ≥ 
40mg/dl), (3) temperature ≥ 38°C, (4) 
decreased consciousness OR seizures OR 
altered mental status OR focal neurologic 
signs. Exclusion criteria: hospitalization of 
fewer than 5 days (to avoid including 
patients with aseptic meningitis without 
brain involvement), positive HIV status, 
meningitis without clinical brain 
involvement, brain abscess, prion disease, 
cerebral malaria, non-infectious CNS-
disease" 
Morishima 
114 
Encephalitis and 
encephalopathy 
associated with 
an influenza 
epidemic in 
Japan 
Japan 
Influenza 
Encephalitis 
winter of 
1998–1999 
"The diagnosis of encephalitis/ 
encephalopathy was made on the basis of 
all clinical signs. All patients had altered 
consciousness or loss of consciousness. 
Patients with meningitis, myelitis, and 
febrile convulsions without prolonged 
unconsciousness were excluded. Postictal 
unconsciousness with prompt recovery 
was classified as febrile convulsion"  
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First 
Author 
Title Country Type/Category 
Year(s) of 
Study 
Clinical Case Definition for Encephalitis 
Olsen 115 
Japanese 
encephalitis 
virus remains an 
important cause 
of encephalitis 
in Thailand 
Thailand Encephalitis 2003-2005 
"the following criteria were approached 
for enrollment: (1) fever or hypothermia 
(i.e., history of fever or documented 
temperature  38 8C or  35 8C); (2) evidence 
of acute brain dysfunction (i.e., 
encephalopathy, central neurological 
findings, or seizures) with onset  14 days 
prior to admission; and (3) clinical 
indication for lumbar puncture as 
determined by a staff physician." 
Schubart 
116 
Short report: 
Role of viruses 
in Kenyan 
children 
presenting with 
acute 
encephalopathy 
in a malaria-
endemic area 
Kenya Cerebral Malaria 1999-2001 
"Differenciation between cerebral malaria, 
bacterial meningitis and viral encephalitis. 
Cerebral malaria: WHO definition. 
Bacterial meningitis confirmed by the 
examination and culture of CSF. Viral 
encephalitis confirmed by looking for 
evidence of herpesviruses and 
enteroviruses." 
Solomon 50 
A cohort study 
to assess the 
new WHO 
Japanese 
encephalitis 
surveillance 
standards 
Viet Nam 
Japanese 
Encephalitis 
Jan-Dec 
1995 
"Clinically, a case of acute encephalitis 
syndrome (AES) is defined as a person of 
any age, at any time of year, with the acute 
onset of fever and a change in mental 
status (including symptoms such as 
confusion, disorientation, coma, or 
inability to talk) AND/OR new onset of 
seizures (excluding simple febrile 
seizures).a Other early clinical findings can 
include an increase in irritability, 
somnolence or abnormal behaviour 
greater than that seen with usual febrile 
illness." 
Ward 90 
Risk of serious 
neurologic 
disease after 
immunization of 
young children 
in Britain and 
Ireland 
UK and 
Ireland 
(British 
Pediatric 
Surveillance 
Unit) 
Encephalitis and 
Severe Illness 
with 
Convulsions and 
Fever 
Oct 1998 - 
Sept 2001 
"pediatricians were requested to report all 
children 2 to 35 months old with 
suspected encephalitis and/or severe 
illness with fever and convulsions- -> 
anaöytical case definition: Fever: 
temperature of 37.5°C; the questionnaire 
asked whether there was a fever and also 
for the maximum temperature recorded at 
any site by any method. Encephalopathy: 
a depressed or altered level of 
consciousness. Case definition of serious 
neurologic disease: any child 2–35 mo old 
with a severe illness with fever and 
convulsions (a) and/or encephalitis (b) 
was included. (a) Severe illness with fever 
and convulsions: (i) with a total duration 
of 30 min; or (ii) followed by 
encephalopathy for 2–23 h; or (iii) 
followed by paralysis or other neurologic 
signs not previously present for 24 h. (b) 
Encephalitis as adapted from 117.(i) 
Encephalopathy for 24 h and 2 of the 
following:fever, convulsions, focal 
neurologic findings ( 24 h), pleocytosis ( 5 
leukocytes per  L CSF), characteristic 
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First 
Author 
Title Country Type/Category 
Year(s) of 
Study 
Clinical Case Definition for Encephalitis 
abnormal results of neuroimaging (CT or 
MRI), herpes simplex virus nucleic acid 
(or nucleic acid of any other virus proven 
to cause encephalitis) in CSF; or (ii) 
postmortem histologic evidence of 
encephalitis. (c) Exclude (i) viral (aseptic) 
meningitis without encephalopathy (ii) the 
following confirmed causes were 
excluded: hypoxic/ischemic; vascular; 
toxic; metabolic, neoplastic, traumatic, and 
pyogenic infections (iii) uncomplicated 
convulsions or a series of convulsions 
lasting 30 min (iv) immunocompromised 
children" 
Table 3. Examples of encephalitis surveillance systems and clinical case definitions used. 
4. Summary and future perspectives 
In conclusion, it may be stated that  
 prospective surveillance systems for encephalitis have been developed in several sites  
 universal case definitions or inclusion criteria are currently not being applied 
 clinical encephalitis case definitions are usually not adjusted to age 
 a large number of prospective studies are laboratory-based with clinical information 
added after the fact 
 evidence-based information on the multiple causes of encephalitis  only slowly 
emerging. 
With the emergence of surveillance systems for encephalitis worldwide, it would be 
desirable to introduce the use of uniform case definitions and clinical criteria allowing meta-
analysis and head-to-head comparisons between studies and sites. As a first step into this 
direction, a model surveillance system has been introduced in the pediatric emergency 
rooms at Charité University Medical Center in Berlin in collaboration with the adjacent 
Robert Koch Institute, as a first cohort to prospectively implement the neurologic case 
definitions by the Brighton Collaboration while assessing vaccine preventable neurologic 
disease along with neurologic adverse events following immunization in the same 
population.  
The Charité Meningitis Surveillance at Charité (MenSCh ) Cohort: Prospective 
Surveillance Systems for CNS inflammation and natural infection. 
At Charité, a prospective surveillance system has been put in place monitoring acute 
presentations of children and adolescents to one of the largest pediatric ERs in Europe. The 
ERs are located in two different areas of Berlin representing an ethnically diverse 
population, including up to 40% of children with migratory background (Turkish, Kurdish, 
Arab/North African, Eastern European). All patients fulfilling predefined case definitions 
while presenting on regular screening days are automatically enrolled, tested immediately 
in close collaboration with epidemiologists and the adjacent Robert Koch Institute and 
followed-up clinically. In the absence of an HMO system in most European countries, this is 
a powerful method to capture a comprehensive sample of a typical pediatric urban tertiary 
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care population with “naturally occurring infection” and adverse events. Precise 
immunization histories are taken at the time of presentation. Case-control and other 
methodology can be used to compensate for lack of randomization. The MenSCh 
(Meningitis Surveillance at Charité) Cohort is a prospective cohort of children presenting 
with signs and symptoms of CNS inflammation/infection to the ER. Presentations are 
classified according to age-adjusted clinical and disease severity scores, but also classified 
according to standardized case definitions for meningitis, encephalitis, myelitis, ADEM, 
GBS, seizure and Bell’s Palsy by the Brighton Collaboration. Confirmed clinical cases 
according to the definitions of the Brighton Collaboration, regardless of the trigger 
(infection, immunization, autoimmune disease), are followed until discharge. Again, 
detailed immunization histories and laboratory data are captured. After case ascertainment 
according to standardized case definitions, patients presenting with rare autoimmune AE 
following immunization will be studied in detail.  
Vaccines are among the most effective methodologies available to date for the prevention of 
infectious diseases of childhood. With declining vaccine acceptance in many parts of the 
world, it will become increasingly important to learn more about the causes of neurologic 
adverse events in children. It is hoped that the MenSch cohort will provide a useful 
contribution to the field while monitoring incidences of vaccine preventable disease 
alongside with adverse events following immunization. 
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